Mechanisms of ischaemic damage to central white matter axons: A quantitative histological analysis using rat optic nerve

Neuroscience

Volumn 94, Issue 4, 1999, Pages 1219-1230

  Garthwaite, G ^a   Brown, G ^b   Batchelor, A M ^a   Goodwin, D A ^a   Garthwaite, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

BW619C89; Iamotrigine; Ischaemia; Na+ channel; Optic nerve; White matter

Indexed keywords

2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE; LAMOTRIGINE; SIPATRIGINE; SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOPATHOLOGY; NERVE FIBER DEGENERATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT; WHITE MATTER;

ANIMALS; ANOXIA; AXONS; GLUCOSE; ISCHEMIA; MICROSCOPY, ELECTRON; NEUROPROTECTIVE AGENTS; OPTIC NERVE; PIPERAZINES; PYRIMIDINES; RATS; RATS, WISTAR; SODIUM CHANNEL BLOCKERS; TRIAZINES;

EID: 0032750453     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00389-9     Document Type: Article

References (72)

1. 2+ exchanger. J. Neurosci. 16:1996;545-552.
2. Almkvist O., Wahlund L.O., Andersson Lundman G., Basun H., Backman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Archs Neurol. 49:1992;626-632.
3. Boiten J., Lodder J. Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke. 22:1991;1374-1378.
4. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. A. Rev. Neurosci. 13:1990;171-182.
5. Crumrine R.C., Bergstrand K., Cooper A.T., Faison W.L., Cooper B.R. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke. 28:1997;2230-2236.
6. De Juan J., Cuenca N., Iniguez C., Fernandez E. Axon types classified by morphometric and multivariate analysis in the rat optic nerve. Brain Res. 585:1992;431-434.
7. De Juan J., Iniguez C., Carreres J. Number, diameter and distribution of the rat optic nerve fibers. Acta anat. basel. 102:1978;294-299.
8. Eriksson A.S., Hoppu K., Nergardh A., Boreus L. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia. 37:1996;769-773.
9. Fehlings M.G., Tator C.H., Linden R.D. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroenceph. clin. Neurophysiol. 74:1989;241-259.
10. Fern R., Davis P., Waxman S.G., Ransom B.R. Axon conduction and survival in CNS white matter during energy deprivation: a developmental study. J. Neurophysiol. 79:1998;95-105.
11. Fern R., Ransom B.R., Stys P.K., Waxman S.G. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J. Pharmac. exp. Ther. 266:1993;1549-1555.
12. Fern R., Ransom B.R., Waxman S.G. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J. Neurophysiol. 74:1995;369-377.
13. Fisher C.M. Lacunar strokes and infarcts: a review. Neurology. 32:1982;871-876.
14. Follis F., Scremin O.U., Blisard K.S., Scremin A.M., Pett S.B., Scott W.J., Kessler R.M., Wernly J.A. Selective vulnerability of white matter during spinal cord ischemia. J. cerebr. Blood Flow Metab. 13:1993;170-178.
15. Forrester J., Peters A. Nerve fibres in optic nerve of rat. Nature. 214:1967;245-247.
16. Garthwaite G., Goodwin D. A. and Garthwaite J. (1999) Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability. Eur. J. Neurosci. (in press).
17. Garthwaite J., Batchelor A.M. A biplanar slice preparation for studying cerebellar synaptic transmission. J. Neurosci. Meth. 64:1996;189-197.
18. Gaspary H.L., Simon R.P., Graham S.H. BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis. Eur. J. Pharmac. 262:1994;197-203.
19. Graham S.H., Chen J., Lan J., Leach M.J., Simon R.P. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. J. Pharmac. exp. Ther. 269:1994;854-859.
20. Graham S.H., Chen J., Sharp F.R., Simon R.P. Limiting ischemic injury by inhibition of excitatory amino acid release. J. cerebr. Blood Flow Metab. 13:1993;88-97.
21. Grunze H., Greene R.W., Moller H.J., Meyer T., Walden J. Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current. Brain Res. 791:1998;330-334.
22. Hammarström A.K.M., Gage P.W. Inhibition of oxidative metabolism increases persistent sodium current in rat CA1 hippocampal neurons. J. Physiol., Lond. 510.3:1998;735-741.
23. Ju Y.K., Saint D.A., Gage P.W. Hypoxia increases persistent sodium current in rat ventricular myocytes. J. Physiol., Lond. 497:1996;337-347.
24. Kawaguchi K., Graham S.H. Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion. Brain Res. 749:1997;131-134.
25. Leach M.J., Swan J.H., Eisenthal D., Dopson M., Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke. 24:1993;1063-1067.
26. Leppanen L., Stys P.K. Ion transport and membrane potential in CNS myelinated axons. I. Normoxic conditions. J. Neurophysiol. 78:1997;2086-2094.
27. Leppanen L., Stys P.K. Ion transport and membrane potential in CNS myelinated axons. II. Effects of metabolic inhibition. J. Neurophysiol. 78:1997;2095-2107.
28. Ma J.Y., Catterall W.A., Scheuer T. Persistent sodium currents through brain sodium channels induced by G protein βγ subunits. Neuron. 19:1997;443-452.
29. Marcoux F.W., Morawetz R.B., Crowell R.M., DeGirolami U., Halsey J.H. Jr. Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 13:1982;339-346.
30. 2+ channels by the neuroprotective agent BW619C89. Neuropharmacology. 36:1997;1795-1798.
31. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends pharmac. Sci. 11:1990;379-387.
32. Meldrum B.S., Swan J.H., Leach M.J., Millan M.H., Gwinn R., Kadota K., Graham S.H., Chen J., Simon R.P. Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res. 593:1992;1-6.
33. Morimoto K., Sato H., Sato K., Sato S., Yamada N. BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. Eur. J. Pharmac. 339:1997;11-15.
34. Muir K.W., Hamilton S.J., Lunnon M.W., Hobbiger S., Lees K.R. Safety and tolerability of 619C89 after acute stroke. Cerebrovasc. Dis. 8:1998;31-37.
35. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke. 28:1997;652-659.
36. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1996;1641-1646.
37. + channels. Proc. natn. Acad. Sci. U.S.A. 93:1996;9270-9275.
38. Ramsay R.E. Use of the new antiepileptic drugs in monotherapy. Neurologist. 4:1998;S11-S15.
39. Ransom B.R., Waxman S.G., Davis P.K. Anoxic injury of CNS white matter: protective effect of ketamine. Neurology. 40:1990;1399-1403.
40. Rees B.E. The distribution of axons according to diameter in the optic nerve and optic tract of the rat. Neuroscience. 22:1987;1015-1024.
41. Requena J., Mullins L.J. Calcium movement in nerve fibres. Q. Rev. Biophys. 12:1979;371-460.
42. Siegel J.M., Nienhuis R., Gulyani S., Ouyang S., Wu M.F., Mignot E., Switzer R.C., McMurry G., Cornford M. Neuronal degeneration in canine narcolepsy. J. Neurosci. 19:1999;248-257.
43. Siesjo B.K. Cell damage in the brain: a speculative synthesis. J. cerebr. Blood Flow Metab. 1:1981;155-185.
44. Smith S.E., al Zubaidy Z.A., Chapman A.G., Meldrum B.S. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Res. 15:1993;101-111.
45. Smith S.E., Hodges H., Sowinski P., Man C.M., Leach M.J., Sinden J.D., Gray J.A., Meldrum B.S. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat. Neuroscience. 77:1997;1123-1135.
46. Smith S.E., Lekieffre D., Sowinski P., Meldrum B.S. Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat. NeuroReport. 4:1993;1339-1342.
47. Smith S.E., Meldrum B.S. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke. 26:1995;117-121.
48. 2+ currents in cortical neurons: functional implications. Eur. J. Pharmac. 307:1996;113-116.
49. 2+ exchanger in mammalian myelinated axons. Brain Res. 776:1997;1-9.
50. Stys P.K. Protective effects of antiarrhythmic agents against anoxic injury in CNS white matter. J. cerebr. Blood Flow Metab. 15:1995;425-432.
51. Stys P.K. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. cerebr. Blood Flow Metab. 18:1998;2-25.
52. + channel blockers on the anoxic response of CNS myelinated axons. NeuroReport. 9:1998;447-453.
53. Stys P.K., Lopachin R.M. Jr. Elemental composition and water content of rat optic nerve myelinated axons during in vitro post-anoxia reoxygenation. Neuroscience. 73:1996;1081-1090.
54. Stys P.K., Lopachin R.M. Mechanisms of calcium and sodium fluxes in anoxic myelinated central nervous system axons. Neuroscience. 82:1998;21-32.
55. Stys P.K., Ransom B.R., Waxman S.G. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia. Neurosci. Lett. 115:1990;293-299.
56. Stys P.K., Ransom B.R., Waxman S.G. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res. 546:1991;18-32.
57. Stys P.K., Ransom B.R., Waxman S.G. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J. Neurophysiol. 67:1992;236-240.
58. Stys P.K., Ransom B.R., Waxman S.G., Davis P.K. Role of extracellular calcium in anoxic injury of mammalian central white matter. Proc. natn. Acad. Sci. U.S.A. 87:1990;4212-4216.
59. + conductance in rat optic nerve axons. Proc. natn. Acad. Sci. U.S.A. 90:1993;6976-6980.
60. 2+ exchanger. J. Neurosci. 12:1992;430-439.
61. Sun F.Y., Faden A.I. Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury. Brain Res. 673:1995;133-140.
62. + channels as targets for neuroprotective drugs. Trends pharmac. Sci. 16:1995;309-316.
63. Teng Y.D., Wrathall J.R. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J. Neurosci. 17:1997;4359-4366.
64. Tsuchida E., Harms J.F., Woodward J.J., Bullock R. A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat. J. Neurosurg. 85:1996;104-111.
65. + channels: a rational and effective strategy against ischemic brain damage. Pharmac. Rev. 48:1996;21-67.
66. Wang S.J., Huang C.C., Hsu K.S., Tsai J.J., Gean P.W. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. NeuroReport. 7:1996;3037-3040.
67. Waxman S.G., Black J.A., Stys P.K., Ransom B.R. Ultrastructural concomitants of anoxic injury and early post-anoxic recovery in rat optic nerve. Brain Res. 574:1992;105-119.
68. Waxman S.G., Ritchie J.M. Molecular dissection of the myelinated axon. Ann. Neurol. 33:1993;121-136.
69. Wiard R.P., Dickerson M.C., Beek O., Norton R., Cooper B.R. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke. 26:1995;466-472.
70. + channels in rat hippocampal neurones. Pflügers Arch. 430:1995;437-446.
71. + channels. Neuroscience. 73:1996;951-962.
72. Yamauchi H., Fukuyama H., Ogawa M., Ouchi Y., Kimura J. Callosal atrophy in patients with lacunar infarction and extensive leukoaraiosis. An indicator of cognitive impairment. Stroke. 25:1994;1788-1793.